Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Intensity Interval Training × Thoracic × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Gastrointestinal 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 172 pembrolizumab 151 Pemetrexed 123 Cisplatin 106 durvalumab 72 Paclitaxel 72 Specimen Handling 56 atezolizumab 55 Nivolumab 54 osimertinib 50 Magnetic Resonance Spectroscopy 43 Docetaxel 41 Gemcitabine 37 Radiosurgery 33 Radiotherapy 32 Etoposide 29 130-nm albumin-bound paclitaxel 29 Drug Therapy 28 cemiplimab 24 Ipilimumab 22 Bevacizumab 21 Cetuximab 20 Immunoglobulin G 19 Disulfides 18 Biopsy 17 Platinum 16 tislelizumab 15 amivantamab 15 Taxes 15 Standard of Care 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06026111 2026-01-21

ENHANCE

Dana-Farber Cancer Institute

Phase NA Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡